PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Edwards Lifesciences Corporation (EW)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS28176E1082
CUSIP28176E108
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$57.52B
EPS$2.30
PE Ratio41.55
PEG Ratio5.49
Revenue (TTM)$6.00B
Gross Profit (TTM)$4.30B
EBITDA (TTM)$1.87B
Year Range$60.57 - $96.12
Target Price$92.92
Short %1.75%
Short Ratio2.57

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Edwards Lifesciences Corporation

Popular comparisons: EW vs. NVNO, EW vs. SYK, EW vs. BAX, EW vs. SPY, EW vs. IHI, EW vs. SCHG, EW vs. VOO, EW vs. MCK, EW vs. LLY, EW vs. DHR

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Edwards Lifesciences Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
25.14%
17.14%
EW (Edwards Lifesciences Corporation)
Benchmark (^GSPC)

S&P 500

Returns By Period

Edwards Lifesciences Corporation had a return of 13.38% year-to-date (YTD) and -0.06% in the last 12 months. Over the past 10 years, Edwards Lifesciences Corporation had an annualized return of 20.72%, outperforming the S&P 500 benchmark which had an annualized return of 10.37%.


PeriodReturnBenchmark
Year-To-Date13.38%5.06%
1 month-8.33%-3.23%
6 months25.14%17.14%
1 year-0.06%20.62%
5 years (annualized)7.92%11.54%
10 years (annualized)20.72%10.37%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20242.91%8.16%12.60%
2023-9.40%-8.03%6.26%12.61%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of EW is 52, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of EW is 5252
Edwards Lifesciences Corporation(EW)
The Sharpe Ratio Rank of EW is 5555Sharpe Ratio Rank
The Sortino Ratio Rank of EW is 4848Sortino Ratio Rank
The Omega Ratio Rank of EW is 4848Omega Ratio Rank
The Calmar Ratio Rank of EW is 5454Calmar Ratio Rank
The Martin Ratio Rank of EW is 5353Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


EW
Sharpe ratio
The chart of Sharpe ratio for EW, currently valued at 0.09, compared to the broader market-2.00-1.000.001.002.003.000.09
Sortino ratio
The chart of Sortino ratio for EW, currently valued at 0.33, compared to the broader market-4.00-2.000.002.004.000.33
Omega ratio
The chart of Omega ratio for EW, currently valued at 1.04, compared to the broader market0.501.001.501.04
Calmar ratio
The chart of Calmar ratio for EW, currently valued at 0.05, compared to the broader market0.001.002.003.004.005.000.05
Martin ratio
The chart of Martin ratio for EW, currently valued at 0.14, compared to the broader market0.0010.0020.0030.000.14
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.76, compared to the broader market-2.00-1.000.001.002.003.001.76
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.57, compared to the broader market-4.00-2.000.002.004.002.57
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.001.002.003.004.005.001.33
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.04, compared to the broader market0.0010.0020.0030.007.04

Sharpe Ratio

The current Edwards Lifesciences Corporation Sharpe ratio is 0.09. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
0.09
1.76
EW (Edwards Lifesciences Corporation)
Benchmark (^GSPC)

Dividends

Dividend History


Edwards Lifesciences Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-33.85%
-4.63%
EW (Edwards Lifesciences Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Edwards Lifesciences Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Edwards Lifesciences Corporation was 52.78%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Edwards Lifesciences Corporation drawdown is 33.85%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-52.78%Dec 31, 2021459Oct 27, 2023
-50.48%Sep 1, 200043Nov 1, 2000165Jun 29, 2001208
-44.02%Oct 5, 2012299Dec 13, 2013217Oct 24, 2014516
-37.11%Feb 12, 2002112Jul 23, 2002199May 7, 2003311
-36.15%Nov 29, 201978Mar 23, 2020110Aug 27, 2020188

Volatility

Volatility Chart

The current Edwards Lifesciences Corporation volatility is 6.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
6.06%
3.27%
EW (Edwards Lifesciences Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Edwards Lifesciences Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items